Antibody production is necessary to be sure of true immunity. Unfortunately, many people who received their two doses of vaccine have shown low to no levels of antibodies in their blood. The question is: what now?
A study is on its way in Hungary on the immune response to various coronavirus vaccines. Still, the first results will not be available until the end of May, Miklós Kásler shared on his video on Saturday.
This will provide an answer to the question of what the government is planning on doing for those whose bodies have not produced enough antibodies to the coronavirus 4-6 weeks after their second vaccination.
444.hu has asked their readers for antibody test results, which were performed in laboratories from blood taken intravenously.
According to Kásler, in addition to the production of antibodies in the body, the central test also checks the cells’ defences.
The central study is of great importance because different types of vaccines work differently. On the one hand, they are far from adapting to the pace at which protection certificates are manufactured and mailed after the first vaccination. And they also differ in how much antibody production the body is put into.
The presence of the antibodies very likely indicates that the body is prepared for the coronavirus. However, the research has not been published by the Hungarian authorities so far, and, in fact, Kásler has for the first time acknowledged that they even exist in Hungary.
Due to the lack of information, many people underwent private testing to ensure that the vaccine elicited an adequate immune response and that they could live their lives more at ease.
If you do not have enough antibodies in your body, you could, in principle, trust that cellular immunity will also protect you. However, there is currently no study available on cellular defences against coronavirus.
That is why a state investigation that checks both would be important. There is quite extensive international documentation on Western vaccines, less on the Russian, and little to none on the Chinese. It is known that at the time of the Hungarian authorisation, the Sinopharm vaccine had hardly been tested in the elderly.
The vaccine is not fundamentally flawed, but in some elderly people, it cannot be shown that antibody production has started.
In her briefing on Monday, Cecília Müller addressed those who do not develop an adequate immune response. He said a very high level of protection develops a week or two after the second vaccination, but no vaccine protects 100 per cent of the virus.
There have always been citizens among us who do not respond adequately to the administration of the vaccine. In this case, they will be protected by community immunity, as their own immune system cannot respond adequately to the vaccine.
Experts and the Chinese experimented with a third vaccination, and there would be plenty of vaccine for it, as the government ordered a total of 5 million doses. According to experts, a completely different type of vaccine could be tried, for which, of course, appropriate tests would have to be performed. Cecília Müller did not mention the additional vaccination as an option.